Clinical Trial: A Pilot Study of Proline Gegliflozin Tablets Combined with Pioglitazone–Metformin Tablets versus Finerenone Tablets Combined with Icodec Insulin in Improving Residual Proteinuria in Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus, and the Gut–Kidney Axis Regulatory Mechanisms (China)

China, Sept. 22 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Pilot Study of Proline Gegliflozin Tablets Combined with Pioglitazone–Metformin Tablets versus Finerenone Tablets Combined with Icodec Insulin in Improving Residual Proteinuria in Early Diabetic Kidney Disease in Type 2 Diabetes Mellitus, and the Gut–Kidney Axis Regulatory Mechanisms'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133065

Registration Time: 2026/09/21

Type: Interventional study

Primary Sponsor: shanghai municipal hospital of TCM

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=343675

Published by HT Digital Content Services with perm...